2nd Circ. Nixes $1.3B Asthma Drug Suit V. AstraZeneca
The Second Circuit on Friday affirmed a win for AstraZeneca AB in a $1.3 billion suit accusing it of breaking a contract to develop a pediatric asthma drug for a San...To view the full article, register now.
Already a subscriber? Click here to view full article